# OLB Group, Inc.: financial statements, quarterly

OLB · Nasdaq · CIK 1314196 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/olb.md) · [Financials](/companies/olb/financials.md) · [Filings](/companies/olb/filings.md) · [Insiders](/companies/olb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/olb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [9.7](/filings/0001213900-23-087063.md) | [5.9 d](/filings/0001213900-25-032064.md) | [3.5](/filings/0001213900-25-044180.md) | [3.5](/filings/0001213900-25-078562.md) | [3.1](/filings/0001213900-25-110806.md) | [2.7 d](/filings/0001213900-26-037906.md) | [2.3](/filings/0001213900-26-058054.md) | [2.3](/filings/0001185185-26-003553.md) | [2.3](/filings/0001213900-25-110806.md) | [1.8 d](/filings/0001213900-26-037906.md) | [1.7](/filings/0001213900-26-058054.md) | [1.3](/filings/0001185185-26-003553.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(1.9)](/filings/0001213900-24-098565.md) | [(18.6) d](/filings/0001213900-25-032064.md) | [(2.9)](/filings/0001213900-25-044180.md) | [(2.6)](/filings/0001213900-25-078562.md) | [(1.6)](/filings/0001213900-25-110806.md) | [(4.5) d](/filings/0001213900-26-037906.md) | [(0.8)](/filings/0001213900-26-058054.md) | [(1.7)](/filings/0001185185-26-003553.md) | [(1.1)](/filings/0001213900-25-110806.md) | [(1.5) d](/filings/0001213900-26-037906.md) | [(1.3)](/filings/0001213900-26-058054.md) | [(1.3)](/filings/0001185185-26-003553.md) |
| Interest expense | $m | [0.0](/filings/0001213900-23-087063.md) | [0.1 d](/filings/0001213900-24-032767.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001185185-26-003553.md) | not reported | not reported | not reported | [0.0](/filings/0001185185-26-003553.md) |
| Net income | $m | [(1.8)](/filings/0001213900-24-098565.md) | [(18.2) d](/filings/0001213900-25-032064.md) | [(2.4)](/filings/0001213900-25-044180.md) | [(2.6)](/filings/0001213900-24-069167.md) | [(1.6)](/filings/0001213900-24-098565.md) | [(4.5) d](/filings/0001213900-25-032064.md) | [(1.1)](/filings/0001213900-25-044180.md) | [(2.1)](/filings/0001185185-26-003553.md) | [(1.2)](/filings/0001213900-25-110806.md) | [(1.5) d](/filings/0001213900-26-037906.md) | [(1.1)](/filings/0001185185-26-003553.md) | [(1.1)](/filings/0001185185-26-003553.md) |
| Diluted EPS | $ per share | [(1.21)](/filings/0001213900-24-098565.md) | not reported | [(0.14)](/filings/0001213900-25-044180.md) | [(1.49)](/filings/0001213900-25-078562.md) | [(0.92)](/filings/0001213900-25-110806.md) | not reported | [(0.47)](/filings/0001213900-26-058054.md) | [(0.66)](/filings/0001185185-26-003553.md) | [(0.13)](/filings/0001213900-25-110806.md) | not reported | [(0.08)](/filings/0001213900-26-058054.md) | [(0.08)](/filings/0001185185-26-003553.md) |
| Basic EPS | $ per share | [(1.21)](/filings/0001213900-24-098565.md) | not reported | [(0.14)](/filings/0001213900-25-044180.md) | [(1.49)](/filings/0001213900-25-078562.md) | [(0.92)](/filings/0001213900-25-110806.md) | not reported | [(0.47)](/filings/0001213900-26-058054.md) | [(0.66)](/filings/0001185185-26-003553.md) | [(0.13)](/filings/0001213900-25-110806.md) | not reported | [(0.08)](/filings/0001213900-26-058054.md) | [(0.08)](/filings/0001185185-26-003553.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001213900-23-087063.md) | [0.2](/filings/0001213900-25-032064.md) | [0.0](/filings/0001213900-24-045276.md) | [0.1](/filings/0001213900-24-069167.md) | [0.0](/filings/0001213900-24-098565.md) | [0.0](/filings/0001213900-25-032064.md) | [0.0](/filings/0001213900-25-044180.md) | not reported | not reported | not reported | not reported | [1.3](/filings/0001185185-26-003553.md) |
| Current assets | $m | [3.6](/filings/0001213900-23-087063.md) | [1.8](/filings/0001213900-25-032064.md) | [1.3](/filings/0001213900-24-045276.md) | [0.6](/filings/0001213900-24-069167.md) | [0.6](/filings/0001213900-24-098565.md) | [0.7](/filings/0001213900-26-037906.md) | [0.8](/filings/0001213900-25-044180.md) | [0.9](/filings/0001213900-25-078562.md) | [0.9](/filings/0001213900-25-110806.md) | [1.1](/filings/0001185185-26-003553.md) | [3.7](/filings/0001213900-26-058054.md) | [2.7](/filings/0001185185-26-003553.md) |
| Total assets | $m | [35.9](/filings/0001213900-23-087063.md) | [19.7](/filings/0001213900-25-032064.md) | [18.3](/filings/0001213900-24-045276.md) | [16.6](/filings/0001213900-24-069167.md) | [15.9](/filings/0001213900-24-098565.md) | [12.7](/filings/0001213900-26-037906.md) | [12.5](/filings/0001213900-25-044180.md) | [12.4](/filings/0001213900-25-078562.md) | [12.2](/filings/0001213900-25-110806.md) | [12.3](/filings/0001185185-26-003553.md) | [15.0](/filings/0001213900-26-058054.md) | [13.9](/filings/0001185185-26-003553.md) |
| Current liabilities | $m | [5.9](/filings/0001213900-23-087063.md) | [7.2](/filings/0001213900-25-032064.md) | [7.1](/filings/0001213900-24-045276.md) | [8.3](/filings/0001213900-24-069167.md) | [8.1](/filings/0001213900-24-098565.md) | [9.4](/filings/0001213900-26-037906.md) | [10.1](/filings/0001213900-25-044180.md) | [5.9](/filings/0001213900-25-078562.md) | [6.9](/filings/0001213900-25-110806.md) | [7.7](/filings/0001185185-26-003553.md) | [6.9](/filings/0001213900-26-058054.md) | [6.8](/filings/0001185185-26-003553.md) |
| Total liabilities | $m | [5.9](/filings/0001213900-23-087063.md) | [7.4](/filings/0001213900-25-032064.md) | [7.1](/filings/0001213900-24-045276.md) | [8.3](/filings/0001213900-24-069167.md) | [9.2](/filings/0001213900-24-098565.md) | [9.5](/filings/0001213900-26-037906.md) | [10.2](/filings/0001213900-25-044180.md) | [6.0](/filings/0001213900-25-078562.md) | [7.0](/filings/0001213900-25-110806.md) | [7.7](/filings/0001185185-26-003553.md) | [6.9](/filings/0001213900-26-058054.md) | [6.8](/filings/0001185185-26-003553.md) |
| Shareholders' equity | $m | [29.9](/filings/0001213900-23-087063.md) | [12.2](/filings/0001213900-25-032064.md) | [11.0](/filings/0001213900-24-045276.md) | [8.3](/filings/0001213900-24-069167.md) | [6.7](/filings/0001213900-24-098565.md) | [3.2](/filings/0001185185-26-003553.md) | [2.3](/filings/0001185185-26-003553.md) | [6.4](/filings/0001185185-26-003553.md) | [5.3](/filings/0001213900-25-110806.md) | [4.6](/filings/0001185185-26-003553.md) | [8.1](/filings/0001185185-26-003553.md) | [7.1](/filings/0001185185-26-003553.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [113 d](/filings/0001213900-24-098565.md) | [81.9 d](/filings/0001213900-25-032064.md) | [(425)](/filings/0001213900-25-044180.md) | [(786) d](/filings/0001213900-25-078562.md) | [(377) d](/filings/0001213900-25-110806.md) | [(1,013) d](/filings/0001213900-26-037906.md) | [(156)](/filings/0001213900-26-058054.md) | [(1,020) d](/filings/0001185185-26-003553.md) | [(116) d](/filings/0001213900-25-110806.md) | [(39.3) d](/filings/0001213900-26-037906.md) | [(1,338)](/filings/0001213900-26-058054.md) | [(1,059) d](/filings/0001185185-26-003553.md) |
| Capital expenditure | $k | [84.2 d](/filings/0001213900-24-098565.md) | [(4.5) d](/filings/0001213900-25-032064.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.7](/filings/0001213900-23-087063.md) | [15.1](/filings/0001213900-24-045276.md) | [1.5](/filings/0001213900-24-069167.md) | [1.5](/filings/0001213900-24-098565.md) | [17.5](/filings/0001213900-25-044180.md) | [1.8](/filings/0001213900-25-078562.md) | [1.8](/filings/0001213900-25-110806.md) | [2.4](/filings/0001213900-26-058054.md) | [4.4](/filings/0001185185-26-003553.md) | [8.7](/filings/0001213900-25-110806.md) | [12.9](/filings/0001213900-26-058054.md) | [14.0](/filings/0001185185-26-003553.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,020,313 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001185185-26-003553.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.